Clinically Proven Care for Dry Age-Related Macular Degeneration
MacuMira is Canada’s first clinically proven, regulatory-approved treatment for dry age-related macular degeneration (AMD). This noninvasive light therapy is designed to help restore lost vision and improve your quality of life.
Dry AMD can make everyday tasks like reading, driving, and recognizing faces more difficult. MacuMira offers a safe, comfortable, and effective way to target the root causes of vision loss and support your retinal health.
If you’re living with dry AMD, MacuMira may offer the relief and results you’ve been waiting for. As part of the Luminus Vision Group, we offer MacuMira at our InVision Eyecare location. Ask your optometrist for more information.
What Is Dry AMD?
Dry AMD is a progressive eye condition that damages the macula, the part of your retina responsible for sharp, central vision. It is one of the leading causes of vision loss in adults over 50. The condition differs from wet AMD, as it is caused by small deposits called drusen that impact the macula.
In its early stages, dry AMD may not cause noticeable symptoms. As it develops, it can lead to:
- Blurry or distorted central vision
- Difficulty seeing in low light
- Reduced colour clarity and contrast sensitivity
MacuMira has been shown to help reverse some of this damage and support long-term macular health.
Benefits of MacuMira
MacuMira can help you:
- Improve central vision: Clinical trials showed vision improvements in all participating patients
- See more clearly in low light: Many patients report better contrast sensitivity and night vision
- Experience results quickly: Some patients notice changes within the first 10 days
MacuMira is designed for patients with early or intermediate dry AMD. If you have been told there is no treatment for your condition, this noninvasive therapy may be a promising option.
Who Is a Candidate for MacuMira?
MacuMira is not suitable for everyone, and a proper eye examination is required to determine eligibility. For example, MacuMira is not effective for those with wet AMD.
This treatment may be considered for patients who:
- Have a confirmed diagnosis of dry age-related macular degeneration
- Are in the early to intermediate stages of the condition
- Have noticed gradual changes in central vision related to AMD
- Are seeking noninvasive options as part of their eye care plan
A comprehensive assessment at Stonebridge Eyecare will help determine whether MacuMira is appropriate for your specific needs.
What Happens During MacuMira Treatment
The treatment is comfortable and noninvasive and involves no injections or medications. The treatment uses a specialized headset that gently delivers microcurrent stimulation to your closed eyes.
Your eye care provider will create a personalized plan, typically starting with four sessions over 10 days, each lasting about 30 minutes.
During treatment:
- You’ll be seated comfortably in an exam chair
- The headset will be placed on your head
- The microcurrent enhances blood flow to nourish the macula and stimulates the production of essential cellular components that support retinal health
To maintain the benefits of the treatment, you’ll typically have follow-up sessions every 2.5 to 3 months.
Ask About MacuMira for Dry AMD
Looking for noninvasive treatment options for dry age-related macular degeneration (AMD)? Luminus Vision Group offers MacuMira at our InVision Eyecare location in Saskatoon.
If you’re interested in learning whether MacuMira is right for you, speak with your optometrist during your next eye exam at Stonebridge Eyecare. They can assess your eyes and, if appropriate, refer you to our InVision team for further care.
Frequently Asked Questions About AMD and MacuMira
No, MacuMira does not cure dry AMD, as age-related macular degeneration cannot be fully cured. However, this noninvasive microcurrent therapy helps support retinal cell health, which can improve visual function and help preserve your vision.
Yes, ongoing comprehensive eye exams are essential to monitor your retinal health and track your macular stability over time. Regular checkups allow our optometry team to assess your progress and adjust your care plan as needed.
Many patients report noticing improvements in visual clarity or contrast sensitivity within the first 10 days of starting treatment. Because individual outcomes depend on your overall retinal health, we recommend booking an evaluation with our team to discuss realistic expectations.
MacuMira uses gentle, painless microcurrent stimulation delivered through closed eyelids to help revitalize light-sensitive cells in the retina. This noninvasive, in-office procedure requires no needles, medications, or surgical incisions.
Patients usually complete an initial series of short in-office sessions followed by periodic maintenance appointments, typically every three months, to sustain visual benefits. Your optometrist will determine a tailored schedule during your appointment based on your eye health.
MacuMira is designed for individuals diagnosed with dry age-related macular degeneration in the early to intermediate stages who wish to proactively support their central vision. If you are interested in learning more about this treatment option, schedule a consultation or comprehensive eye exam at Stonebridge Eyecare today.
Visit Our Location
We’re located in Stonebridge, on the corner of Cope Lane and Stonebridge Boulevard. Find us next to the Saskatoon Dermatology Centre and Stonebridge Dental Centre. Free parking is available.
Our Address
Contact Information
- Phone: 306-664-2638
- Fax: 306-653-5822
- Email: secadmin@yxevision.ca
After Hours Emergencies: 306-371-9911
Hours of Operation
A Look
Inside Stonebridge Eyecare
See What Our Patients Are Saying
